These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34562302)

  • 1. Diversity of pathophysiology in type 2 diabetes shown by islet pathology.
    Mizukami H; Kudoh K
    J Diabetes Investig; 2022 Jan; 13(1):6-13. PubMed ID: 34562302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Islet amyloid and diabetes mellitus type 2].
    Höppener JW; Nieuwenhuis MG; Vroom TM; Lips CJ
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):1995-2000. PubMed ID: 11072517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic pathology in non-insulin dependent diabetes (NIDDM).
    Clark A; de Koning EJ; Hattersley AT; Hansen BC; Yajnik CS; Poulton J
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S39-47. PubMed ID: 8529518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
    Hull RL; Westermark GT; Westermark P; Kahn SE
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3629-43. PubMed ID: 15292279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Porte D
    Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits.
    Westermark GT; Christmanson L; Terenghi G; Permerth J; Betsholtz C; Larsson J; Polak JM; Westermark P
    Diabetologia; 1993 Apr; 36(4):323-8. PubMed ID: 8477877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.
    Butler AE; Janson J; Soeller WC; Butler PC
    Diabetes; 2003 Sep; 52(9):2304-14. PubMed ID: 12941770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet amyloid polypeptide and type 2 diabetes.
    Marzban L; Park K; Verchere CB
    Exp Gerontol; 2003 Apr; 38(4):347-51. PubMed ID: 12670620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons.
    Guardado-Mendoza R; Davalli AM; Chavez AO; Hubbard GB; Dick EJ; Majluf-Cruz A; Tene-Perez CE; Goldschmidt L; Hart J; Perego C; Comuzzie AG; Tejero ME; Finzi G; Placidi C; La Rosa S; Capella C; Halff G; Gastaldelli A; DeFronzo RA; Folli F
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13992-7. PubMed ID: 19666551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
    Spijker HS; Song H; Ellenbroek JH; Roefs MM; Engelse MA; Bos E; Koster AJ; Rabelink TJ; Hansen BC; Clark A; Carlotti F; de Koning EJ
    Diabetes; 2015 Aug; 64(8):2928-38. PubMed ID: 25918235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
    Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2002 Jul; 3(4):86-108. PubMed ID: 12110767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
    Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
    Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients.
    Ueberberg S; Nauck MA; Uhl W; Montemurro C; Tannapfel A; Clark A; Meier JJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32271378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islet dysfunction in type 2 diabetes mellitus.
    Hu F; Qiu X; Bu S
    Arch Physiol Biochem; 2020 Jul; 126(3):235-241. PubMed ID: 30293453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.